Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 3, Mars 2014
Page(s) 274 - 279
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20143003015
Publié en ligne 31 mars 2014
  1. LeCouter J, Kowalski J, Foster J, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001 ; 412 : 877–884. [CrossRef] [PubMed] [Google Scholar]
  2. Maldonado-Perez D, Evans J, Denison F, et al. Potential roles of the prokineticins in reproduction. Trends Endocrinol Metab 2007 ; 18 : 66–72. [CrossRef] [PubMed] [Google Scholar]
  3. Bullock CM, Li JD, Zhou QY. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol Pharmacol 2004 ; 65 : 582–588. [CrossRef] [PubMed] [Google Scholar]
  4. Lin R, LeCouter J, Kowalski J, Ferrara N. Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 2002 ; 277 : 8724–8729. [CrossRef] [PubMed] [Google Scholar]
  5. Soga T, Matsumoto S, Oda T, et al. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 2002 ; 1579 : 173–179. [CrossRef] [PubMed] [Google Scholar]
  6. Nebigil CG. Prokineticin receptors in cardiovascular function: foe or friend?. Trends Cardiovasc Med 2009 ; 19 : 55–60. [CrossRef] [PubMed] [Google Scholar]
  7. Brouillet S, Hoffmann P, Benharouga M, et al. Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell 2010 ; 21 : 2832–2843. [CrossRef] [PubMed] [Google Scholar]
  8. Brouillet S, Hoffmann P, Feige JJ, Alfaidy N. EG-VEGF: a key endocrine factor in placental development. Trends Endocrinol Metab 2012 ; 23 : 501–508. [CrossRef] [PubMed] [Google Scholar]
  9. Matsumoto S, Yamazaki C, Masumoto KH, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA 2006 ; 103 : 4140–4145. [CrossRef] [Google Scholar]
  10. Pitteloud N, Zhang C, Pignatelli D, et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 2007 ; 104 : 17447–17452. [CrossRef] [Google Scholar]
  11. Dode C, Teixeira L, Levilliers J, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2, prokineticin receptor-2. PLoS Genet 2006 ; 2 : e175. [CrossRef] [PubMed] [Google Scholar]
  12. Guimiot F, Teixeira L, Dode C, et al. Syndrome de Kallmann : une séquence fœtopathologique. Med Sci (Paris) 2011 ; 27 : 135–137. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. LeCouter J, Lin R, Tejada M, et al. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 2003 ; 100 : 2685–2690. [CrossRef] [Google Scholar]
  14. Samson M, Peale FV, Jr, Frantz G, et al. Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 2004 ; 89 : 4078–4088. [CrossRef] [PubMed] [Google Scholar]
  15. Tu LH, Yu LL, Xiong CL, Zhang HP. Potential role of prokineticin 2 in experimental varicocele-induced rat testes. Urology 2012 ; 80 : 952 e15–9. [Google Scholar]
  16. Pasquali D, Rossi V, Staibano S, et al. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinology 2006 ; 147 : 4245–4251. [CrossRef] [PubMed] [Google Scholar]
  17. Ferrara N, LeCouter J, Lin R, Peale F. EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors. Biochim Biophys Acta 2004 ; 1654 : 69–78. [PubMed] [Google Scholar]
  18. Fraser HM, Bell J, Wilson H, et al. Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. J Clin Endocrinol Metab 2005 ; 90 : 427–434. [CrossRef] [PubMed] [Google Scholar]
  19. Hoffmann P, Feige JJ, Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 2006 ; 147 : 1675–1684. [CrossRef] [PubMed] [Google Scholar]
  20. Ferrara N, Frantz G, LeCouter J, et al. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 2003 ; 162 : 1881–1893. [CrossRef] [PubMed] [Google Scholar]
  21. Gao MZ, Zhao XM, Sun ZG, et al. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2011 ; 95 : 673–678. [CrossRef] [PubMed] [Google Scholar]
  22. Hoffmann P, Saoudi Y, Benharouga M, et al. Role of EG-VEGF in human placentation: Physiological and pathological implications. J Cell Mol Med 2009 ; 13 : 2224–2235. [CrossRef] [PubMed] [Google Scholar]
  23. Haouzi D, Mahmoud K, Fourar M, et al. Identification of new biomarkers of human endometrial receptivity in the natural cycle. Hum Reprod 2009 ; 24 : 198–205. [CrossRef] [PubMed] [Google Scholar]
  24. Shaw JL, Denison FC, Evans J, et al. Evidence of prokineticin dysregulation in fallopian tube from women with ectopic pregnancy. Fertil Steril 2010 ; 94 : 1601–1608 e1. [CrossRef] [PubMed] [Google Scholar]
  25. Su MT, Lin SH, Lee IW, et al. Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss. Hum Reprod 2010 ; 25 : 2923–2930. [CrossRef] [PubMed] [Google Scholar]
  26. Salker M, Teklenburg G, Molokhia M, et al. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions, causes recurrent pregnancy loss. PLoS One 2010 ; 5 : e10287. [CrossRef] [PubMed] [Google Scholar]
  27. Su MT, Lin SH, Chen YC, et al. Prokineticin receptor variants (PKR1–I379V and PKR2–V331M) are protective genotypes in human early pregnancy. Reproduction 2013 ; 146 : 63–73. [CrossRef] [PubMed] [Google Scholar]
  28. Brouillet S, Hoffmann P, Chauvet S, et al. Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci 2012 ; 69 : 1537–1550. [CrossRef] [PubMed] [Google Scholar]
  29. Brouillet S, Murthi P, Hoffmann P, et al. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cell Mol Life Sci 2013 ; 70 : 511–525. [CrossRef] [PubMed] [Google Scholar]
  30. Catalano RD, Lannagan TR, Gorowiec M, et al. Prokineticins: novel mediators of inflammatory and contractile pathways at parturition ?. Mol Hum Reprod 2010 ; 16 : 311–319. [CrossRef] [PubMed] [Google Scholar]
  31. Rigourd V, Chelbi ST, Vaiman D. La pré-éclampsie. Med Sci (Paris) 2008 ; 24 : 1017–1019. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.